You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Active, not recruiting
  • Head and Neck Basaloid Carcinoma
  • +23 more
  • Tucson, Arizona
  • +5 more
2021-07-01
Jul 1, 2021
E
Recruiting
  • Glottic Carcinoma
  • +5 more
  • routines
  • Shanghai, Shanghai, China
    Lei Tao
2021-05-26
May 26, 2021
C
Recruiting
  • Head and Neck Cancer
  • +26 more
  • Liquid biopsy
  • Copenhagen, Region Hovedstaden, Denmark
    University Hospital of Copenhagen, Rigshospitalet
2021-09-14
Sep 14, 2021
B
Recruiting
  • Papillary Renal Cell Carcinoma
  • +8 more
  • Boston, Massachusetts
  • +3 more
2021-11-29
Nov 29, 2021
H
Recruiting
  • Merkel Cell Carcinoma
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
2021-09-14
Sep 14, 2021
A
Not yet recruiting
  • Urinary Bladder Squamous Cell Carcinoma
  • Radiotherapy
  • (no location specified)
2021-08-17
Aug 17, 2021
W
Recruiting
  • Head Neck Cancer
  • +5 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Health Sciences
2021-05-28
May 28, 2021
E
Not yet recruiting
  • Recurrent Hepatocellular Carcinoma
  • +7 more
  • Scottsdale, Arizona
  • +1 more
2021-10-22
Oct 22, 2021
N
Recruiting
  • Nasopharyngeal Carcinoma
  • Singapore, Singapore
    National Cancer Center Singapore
2021-05-24
May 24, 2021
N
Not yet recruiting
  • Adrenocortical Carcinoma
  • Pembrolizumab / Lenvatinib
  • (no location specified)
2021-11-15
Nov 15, 2021
S
Recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • +2 more
  • Sintilimab, Nab-paclitaxel, Carboplatin
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital
2021-10-20
Oct 20, 2021
A
Not yet recruiting
  • Hepatocellular Carcinoma
  • patients with hepatocellular carcinoma
  • (no location specified)
2021-09-09
Sep 9, 2021
M
Recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +24 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2021-10-25
Oct 25, 2021
S
Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Recurrent or Metastatic Nasopharyngeal Carcinoma
  • Toripalimab and Anlotinib
  • (no location specified)
2021-08-05
Aug 5, 2021
U
Active, not recruiting
  • Nasopharyngeal Carcinoma
    • Toronto, Ontario, Canada
      University Health Network, Princess Margaret Cancer Centre
    2021-10-21
    Oct 21, 2021
    F
    Recruiting
    • Recurrent Nasopharyngeal Carcinoma
    • +4 more
    • Shanghai, China
      Eye and ENT Hospital of Fudan University
    2021-06-11
    Jun 11, 2021
    H
    Active, not recruiting
    • Squamous Cell Carcinoma
    • +7 more
    • Tampa, Florida
    • +1 more
    2021-11-18
    Nov 18, 2021
    S
    Recruiting
    • Basal Cell Carcinoma
    • 1064 nm long-pulse Nd:YAG laser
    • Spring Hill, Tennessee
      Skin & Allergy Center
    2021-11-05
    Nov 5, 2021
    U
    Recruiting
    • Adrenocortical Carcinoma
      • Wuerzburg, Germany
        University of Wuerzburg
      2021-06-01
      Jun 1, 2021
      T
      Not yet recruiting
      • Resectable Esophageal Squamous Cell Carcinoma
      • (no location specified)
      2021-08-17
      Aug 17, 2021
      U
      Recruiting
      • Basal Cell Carcinoma
      • +2 more
      • 1064 nm long-pulse Nd:YAG laser
      • Irvine, California
        UCI Health Gottschalk Medical Plaza
      2021-02-04
      Feb 4, 2021
      F
      Recruiting
      • Locally Advanced Nasopharyngeal Carcinoma
      • Induction Chemotherapy
      • +2 more
      • Guangzhou, Guang Dong, China
        The First Affiliated Hospital of Sun Yat-sen University
      2021-09-21
      Sep 21, 2021
      Y
      Not yet recruiting
      • Locally Advanced Nasopharyngeal Carcinoma
      • Seoul, Korea, Republic of
        Yonsei University Health System, Severance Hospital
      2021-05-26
      May 26, 2021
      S
      Recruiting
      • Ewing Sarcoma
      • +13 more
      • Santa Monica, California
        Sarcoma Oncology Research Center
      2021-05-05
      May 5, 2021